Central Pacific Bank Trust Division Biomarin Pharmaceutical Inc Transaction History
Central Pacific Bank Trust Division
- $827 Billion
- Q3 2025
A detailed history of Central Pacific Bank Trust Division transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 5,250 shares of BMRN stock, worth $287,332. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,250
Previous 4,750
10.53%
Holding current value
$287,332
Previous $261 Million
8.9%
% of portfolio
0.03%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding BMRN
# of Institutions
667Shares Held
182MCall Options Held
1.48MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...